Pharmafile Logo
Pharmafocus logo
Advanced Search

PCT claims bullying over private contract

June 3, 2004

An NHS trust chairman has accused the government of bullying it into awarding a contract to a private firm, resulting …

News

Lilly launches first non-stimulant ADHD treatment

June 3, 2004

News

Unmet needs in arthritis

June 3, 2004

Although there is no cure for rheumatoid arthritis (RA), a wide range of drugs are involved in its treatment. Similar …

Feature

CROs: flexible or overstretched?

June 3, 2004

If only I had known then what I know now about the labyrinthine world of Contract Research Organisations (CROs). This …

Feature

Lost in translation?

June 2, 2004

Feature

Counterfeit medicines on the rise

June 1, 2004

The World Health Organisation (WHO) estimates that up to 10% of medicines worldwide may be counterfeit, costing the pharmaceutical industry …

Feature

MPs call for NHS obesity reduction targets

May 27, 2004

News

Making the most of your talent

May 27, 2004

The vast majority of pharma executives would argue that having a large number of products in any company's portfolio should …

Feature

Roche prescribing data to support NICE uptake

May 27, 2004

Roche is to provide NICE with regular updates on patient access to its treatments to help increase the uptake of …

News

Arrhythmias added to ‘ahead of schedule’ heart disease NSF

May 27, 2004

News

NICE strikes deal with industry on data confidentiality

May 26, 2004

The industry and NICE have reached agreement on how the cost and clinical effectiveness body can meet demands for transparency …

News

The science of compliance

May 26, 2004

Feature

NICE recommendation on Glivec criticised

May 25, 2004

News

The downside to downsizing

May 24, 2004

It used to be that the pharmaceutical industry was virtually recession-proof. When times were bad, the unemployed had more time …

Feature

Sanofi takes charge of arranged marriage

May 24, 2004

Sanofi-Synthelabo chief executive Jean-Francois Dehecq is preparing his company to merge with larger Franco-German neighbours Aventis to create the world's …

News

Velcade launched in UK

May 24, 2004

Velcade, the first in a new class of cancer drugs has been launched in the UK as a third line …

News

UCB snaps up arthritis drug and Celltech in one

May 20, 2004

Brussels-based UCB is to buy the UK's number one biotech company Celltech for around $1.5 billion, creating the world's fifth …

News

AstraZeneca issues Crestor safety warning

May 20, 2004

AstraZeneca has written to healthcare professionals in the UK after a small number of patients reported serious side effects after …

News

Addressing the gender divide

May 20, 2004

A recent report by the Equal Opportunity Commission (EOC), Promoting Gender Equality in Health, has highlighted a significant omission which …

Feature

GSK establishes strategic link with Theravance

May 20, 2004

GlaxoSmithKline has paid $129 million to a small US biotech company for a three-year worldwide licensing option on all the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025